Epithelial Cell Migration and Proliferation Patterns During Initial Wound Closure in Normal Mice and an Experimental Model of Limbal Stem Cell Deficiency.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited Medium: Internet ISSN: 1552-5783 (Electronic) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE
    • Publication Information:
      Publication: Brookline Ma : Association For Research In Vision And Ophthalmology (Arvo)
      Original Publication: St. Louis, Mosby.
    • Subject Terms:
      Cell Movement* ; Cell Proliferation*; Corneal Injuries/*physiopathology ; Limbus Corneae/*cytology ; Stem Cells/*physiology ; Wound Healing/*physiology; Animals ; Corneal Injuries/pathology ; Disease Models, Animal ; Epithelium, Corneal/cytology ; Epithelium, Corneal/physiology ; Female ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic
    • Abstract:
      Purpose: Establishing the dynamics of corneal wound healing is of vital importance to better understand corneal inflammation, pathology, and corneal regeneration. Numerous studies have made great strides in investigating multiple aspects of corneal wound healing; however, some aspects remain to be elucidated. This study worked toward establishing (1) if epithelial limbal stem cells (LSCs) are necessary for healing all corneal wounds, (2) the mechanism by which epithelial cells migrate toward the wound, and (3) if centrifugal epithelial cell movement exists.
      Methods: To establish different aspects of corneal epithelial wound healing we subjected mice lacking hyaluronan synthase 2 (previously shown to lack LSCs) and wild-type mice to different corneal debridement injury models.
      Results: Our data show that both LSCs and corneal epithelial cells contribute toward closure of corneal wounds. In wild-type mice, removal of the limbal rim delayed closure of 1.5-mm wounds, and not of 0.75-mm wounds, indicating that smaller wounds do not rely on LSCs as do larger wounds. In mice shown to lack LSCs, removal of the limbal rim did not affect wound healing, irrespective of the wound size. Finally, transient amplifying cells and central epithelial cells move toward a central corneal wound in a centripetal manner, whereas central epithelial cells may move in a centrifugal manner to resurface peripheral corneal wounds.
      Conclusions: Our findings show the dimensions of the corneal wound dictate involvement of LSCs. Our data suggest that divergent findings by different groups on the dynamics of wound healing can be in part owing to differences in the wounding models used.
    • References:
      Invest Ophthalmol Vis Sci. 2020 May 11;61(5):7. (PMID: 32392315)
      Ophthalmology. 2009 May;116(5):856-63. (PMID: 19410942)
      Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3713-3727. (PMID: 30046813)
      Stem Cells. 2015 Jan;33(1):157-69. (PMID: 24966117)
      Nat Commun. 2016 Aug 08;7:12388. (PMID: 27499113)
      Exp Eye Res. 2015 Nov;140:75-84. (PMID: 26297801)
      J Invest Dermatol. 1983 Jul;81(1 Suppl):121s-7s. (PMID: 6190957)
      Stem Cell Res. 2018 Dec;33:185-198. (PMID: 30439642)
      Exp Eye Res. 2019 May;182:74-84. (PMID: 30905716)
      Stem Cell Reports. 2017 Oct 10;9(4):1081-1096. (PMID: 28943255)
      Br J Ophthalmol. 1944 Jan;28(1):26-40. (PMID: 18169982)
      Cell. 1989 Apr 21;57(2):201-9. (PMID: 2702690)
      Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5279-86. (PMID: 18515566)
      Exp Eye Res. 2016 Apr;145:88-92. (PMID: 26607808)
      Stem Cells. 2012 Sep;30(9):2032-43. (PMID: 22821715)
      Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1630-1640. (PMID: 29625489)
      Stem Cells Transl Med. 2017 May;6(5):1356-1365. (PMID: 28276172)
      PLoS One. 2015 Dec 16;10(12):e0144571. (PMID: 26673160)
      Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1137-44. (PMID: 20358217)
      Stem Cell Reports. 2019 Jan 8;12(1):14-28. (PMID: 30554917)
      PLoS One. 2016 Apr 01;11(4):e0152889. (PMID: 27035345)
      Ophthalmology. 1995 Oct;102(10):1476-85. (PMID: 9097795)
      Exp Eye Res. 2002 Feb;74(2):199-204. (PMID: 11950230)
      Vet Ophthalmol. 2010 May;13(3):144-50. (PMID: 20500713)
      Exp Eye Res. 2017 Jan;154:22-29. (PMID: 27818315)
      Ocul Surf. 2019 Jul;17(3):447-457. (PMID: 31125784)
      Trans Am Ophthalmol Soc. 1944;42:371-83. (PMID: 16693359)
      Stem Cells. 2015 Jan;33(1):230-9. (PMID: 25187087)
      Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7338-44. (PMID: 26559480)
      Invest Ophthalmol Vis Sci. 1991 Jan;32(1):96-105. (PMID: 1702774)
      Nature. 1971 Feb 19;229(5286):560-1. (PMID: 4925352)
      Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
      J Cell Biol. 1986 Jul;103(1):49-62. (PMID: 2424919)
      Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1050-1062. (PMID: 30897620)
      Stem Cells. 2011 Jan;29(1):57-66. (PMID: 20957740)
      Eye (Lond). 2008 Sep;22(9):1161-7. (PMID: 17558385)
      Proc Natl Acad Sci U S A. 2019 Dec 16;:. (PMID: 31843909)
      Exp Eye Res. 2016 Jun;147:1-11. (PMID: 27085211)
      PLoS One. 2017 Feb 2;12(2):e0171008. (PMID: 28152010)
      Invest Ophthalmol. 1976 Jan;15(1):4-14. (PMID: 1245378)
      Invest Ophthalmol Vis Sci. 1986 Apr;27(4):464-73. (PMID: 3957565)
      Stem Cells. 2007 Jun;25(6):1402-9. (PMID: 17332511)
      Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):5864-5871. (PMID: 27802516)
      Nature. 2008 Nov 13;456(7219):250-4. (PMID: 18830243)
      J Appl Physiol (1985). 2004 Aug;97(2):641-7. (PMID: 15064298)
      Stem Cell Res. 2015 Nov;15(3):665-677. (PMID: 26554513)
      Invest Ophthalmol Vis Sci. 1979 Aug;18(8):767-84. (PMID: 457355)
      Cornea. 2012 Nov;31 Suppl 1:S68-73. (PMID: 23038039)
      Invest Ophthalmol Vis Sci. 2003 Feb;44(2):558-66. (PMID: 12556383)
      Lab Invest. 2020 Apr;100(4):630-642. (PMID: 31653968)
      Sci Rep. 2017 Jul 12;7(1):5169. (PMID: 28701781)
      Sci Rep. 2016 Oct 11;6:35085. (PMID: 27725776)
      Invest Ophthalmol Vis Sci. 1983 Oct;24(10):1442-3. (PMID: 6618809)
      Cell Rep. 2018 Jan 9;22(2):323-331. (PMID: 29320729)
      Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4407-4421. (PMID: 28863216)
      Invest Ophthalmol Vis Sci. 2006 Feb;47(2):545-51. (PMID: 16431949)
      Eur J Cell Biol. 2006 Aug;85(8):803-11. (PMID: 16759736)
      Mol Vis. 2016 Aug 09;22:990-1004. (PMID: 27563231)
      BMC Complement Altern Med. 2013 Nov 27;13:337. (PMID: 24279635)
      Am J Ophthalmol. 1966 Jan;61(1):55-63. (PMID: 5904378)
      Invest Ophthalmol Vis Sci. 1985 Sep;26(9):1296-9. (PMID: 4030257)
      Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8132-7. (PMID: 21896841)
      J Vis Exp. 2016 Nov 17;(117):. (PMID: 27911382)
    • Grant Information:
      R01 EY029289 United States EY NEI NIH HHS
    • Publication Date:
      Date Created: 20200814 Date Completed: 20210106 Latest Revision: 20210514
    • Publication Date:
      20221213
    • Accession Number:
      PMC7441334
    • Accession Number:
      10.1167/iovs.61.10.27
    • Accession Number:
      32790859